GENINUS About GENINUS
Current status of the company

※ As of the end of Feb., 2021

Core areas of research and technology
Current status of services launched
2018
“Technologies & Patents transfer &
  Initial Investment Attraction”
2018
09
Patented technology transfer contract (SMC)
12
Secured Series A investment
2019
“Technology Commercialization &
  & Service Launch”
2019
01
Launched service for LiquidSCAN®
03
Launched HealthSCAN® Ver. 1
for management of body weight
04
Launched InsideMe®
08
Launched WithMe®
2020
“Strategic Patnership &
  & Service elevation”
2020
01
Launched neoSTATION
Launched Celinus™ (Singlecell analysis)
02
Launched HealthSCAN® Ver. 2
03
Launched service for SingleCell research
05
Launched CancerSCAN ver.3
06
Launched A genetic test for Ophthalmology
08
Planning to launch WithMe® Ver. 2
Launched WithMe ver.2
2021
“Continuous Research and
  Development & extend business field”
2021
01
Launched HealthSCAN ver.2
Overseas businesses
  • Cooperation
  • R&D
  • Business + R&D
  • USA
  • England
  • Saudi Arabia
  • China
  • Korea
  • Japan
  • Australia
  • India

  • Singapore